L'AIAC et ISDE publient le plus récent rapport sur l'état de l'industrie aérospatiale canadienne
11 juil. 2024 14h00 HE
|
L'Association des industries aérospatiales du Canada
OTTAWA, 11 juill. 2024 (GLOBE NEWSWIRE) -- Des données récemment publiées révèlent que l'industrie aérospatiale canadienne montre des signes de reprise économique et continue d'être un moteur...
AIAC & ISED Release Latest State Of Canada’s Aerospace Industry Report
11 juil. 2024 14h00 HE
|
Aerospace Industries Association of Canada (AIAC)
Aerospace Industries Association of Canada, in partnership with ISED, release the latest State of Canada’s Aerospace Industry Report.
Tevogen Bio’s R&D Leadership Discusses The Promise of Its Genetically Unmodified, Off-The-Shelf T Cell Technology For The Treatment of Infectious Diseases, Cancers, and Neurological Disorders With Nasdaq's Kristina Ayanian
10 juil. 2024 08h05 HE
|
Tevogen Bio Inc
Dr. Flomenberg and Dr. Grosso are leading experts in T cell biology and its clinical applicationsTevogen’s ExacTcell™ platform is designed to address current cost, and patient accessibility...
Resonac Announces New US-JOINT Consortium; Ten Partners to Collaborate on Next-Generation Semiconductor Packaging in Silicon Valley
08 juil. 2024 08h07 HE
|
Resonac Holdings Corporation
Resonac Corporation today unveiled a new consortium of ten partners, called “US-JOINT,” for its semiconductor back-end process R&D in Silicon Valley.
CBIH Charts Path to Future Leadership in Cannabis Medicine
08 juil. 2024 08h00 HE
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
A letter from our desk HOUSTON, July 08, 2024 (GLOBE NEWSWIRE) -- Since the start of the year, Cannabis Bioscience International Holdings (OTCMKTS: CBIH) has embarked on a transformative journey...
CBIH advances Cancer Care with Novel Cannabis Patents for Breast and Pancreatic Cancers
01 juil. 2024 08h00 HE
|
CANNABIS BIOSCIENCE INTERNATIONAL HOLDINGS, INC.
Cannabis Bioscience International Holdings (OTCMKTS: CBIH) is excited to announce the submission of our inaugural pair of patents, focusing on novel treatm
Nxera Pharma Receives US$10 Million from AbbVie as Collaboration Targeting Neurological Diseases Achieves First R&D Milestone
26 juin 2024 19h05 HE
|
Nxera Pharma
Tokyo, Japan and Cambridge, UK, 27 June 2024 - Nxera Pharma Co. Ltd (“Nxera”; TSE 4565), announces that it has reached an important R&D milestone under its multi-target discovery collaboration...
ABB investing $35 million in new U.K. earthing and lightning protection factory
25 juin 2024 07h30 HE
|
ABB Electrification
ZURICH, SWITZERLAND, June 25, 2024 (GLOBE NEWSWIRE) -- Technologically advanced factory will increase production of Furse® earthing and lightning protection solutions, used in more than 20...
Genetec expands global presence with new R&D hubs and Experience Centers to support rapid growth
29 mai 2024 09h00 HE
|
Genetec, Inc.
Montreal, QC, Canada, May 29, 2024 (GLOBE NEWSWIRE) -- Genetec Inc. (“Genetec”), a leading technology provider of unified security, public safety, operations, and business intelligence solutions,...
Optimi Health Receives Export Permit from Health Canada to Ship MDMA To Tel Aviv University's Institute for Psychedelic Research
09 mai 2024 08h00 HE
|
Optimi Health Corp.
Export Permit granted: Optimi's Shipment of MDMA active pharmaceutical ingredient (API) to Israel marks the Company’s first international export